Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-04
DOI
10.1038/s41598-017-17376-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of AtherosclerosisSignificance
- (2016) Lea Rahtu-Korpela et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner
- (2016) Susan F. Fitzpatrick et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia
- (2016) Elke Marsch et al. EUROPEAN HEART JOURNAL
- The role of HIF in immunity and inflammation
- (2016) Eoin P. Cummins et al. MOLECULAR ASPECTS OF MEDICINE
- Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
- (2016) Mun Chiang Chan et al. MOLECULAR ASPECTS OF MEDICINE
- Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis
- (2016) S Neitemeier et al. Cell Death & Disease
- HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
- (2015) T. Bishop et al. CIRCULATION RESEARCH
- Muscle composition is regulated by a Lox-TGF feedback loop
- (2015) L. Kutchuk et al. DEVELOPMENT
- PHD1 regulates p53-mediated colorectal cancer chemoresistance
- (2015) S. Deschoemaeker et al. EMBO Molecular Medicine
- Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis
- (2015) Murtaza M. Tambuwala et al. JOURNAL OF CONTROLLED RELEASE
- HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond
- (2015) Patrick H. Maxwell et al. Nature Reviews Nephrology
- The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression
- (2015) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- Caught in the cross fire: p53 in inflammation
- (2014) Tomer Cooks et al. CARCINOGENESIS
- Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
- (2014) Zoi Michailidou et al. DIABETES
- HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects Against Obesity and Metabolic Dysfunction
- (2014) L. Rahtu-Korpela et al. DIABETES
- Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
- (2014) Holger K. Eltzschig et al. NATURE REVIEWS DRUG DISCOVERY
- Over-expression of prolyl hydroxylase-1 blocks NF-κB-mediated cyclin D1 expression and proliferation in lung carcinoma cells
- (2014) Xiao Xie et al. Cancer Genetics
- Prolyl 4-hydroxylases, master regulators of the hypoxia response
- (2013) J. Myllyharju Acta Physiologica
- The impact of hypoxia on cell death pathways
- (2013) Colin R. Lenihan et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeting the HIF pathway in inflammation and immunity
- (2013) Carsten C Scholz et al. CURRENT OPINION IN PHARMACOLOGY
- PHD1 Links Cell-Cycle Progression to Oxygen Sensing through Hydroxylation of the Centrosomal Protein Cep192
- (2013) Sandra C. Moser et al. DEVELOPMENTAL CELL
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis
- (2013) S Keely et al. Mucosal Immunology
- Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes
- (2013) Cullen M Taniguchi et al. NATURE MEDICINE
- Regulation of IL-1 -induced NF- B by hydroxylases links key hypoxic and inflammatory signaling pathways
- (2013) C. C. Scholz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis
- (2012) A. Laitala et al. BLOOD
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway
- (2012) Azadeh Arabi et al. Nature Communications
- Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
- (2011) Sarah R. Walmsley et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxia and Inflammation
- (2011) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Elution Conditions for Native Co-Immunoprecipitation
- (2011) Robin Antrobus et al. PLoS One
- The Hydroxylase Inhibitor Dimethyloxallyl Glycine Attenuates Endotoxic Shock Via Alternative Activation of Macrophages and IL-10 Production by B1 Cells
- (2011) Emily Hams et al. SHOCK
- Reciprocal influence of the p53 and the hypoxic pathways
- (2011) A Sermeus et al. Cell Death & Disease
- Disruption of Hypoxia-Inducible Transcription Factor-Prolyl Hydroxylase Domain-1 (PHD-1−/−) Attenuates Ex Vivo Myocardial Ischemia/Reperfusion Injury Through Hypoxia-Inducible Factor-1α Transcription Factor and Its Target Genes in Mice
- (2010) Ram Sudheer Adluri et al. ANTIOXIDANTS & REDOX SIGNALING
- Loss of Prolyl Hydroxylase-1 Protects Against Colitis Through Reduced Epithelial Cell Apoptosis and Increased Barrier Function
- (2010) Murtaza M. Tambuwala et al. GASTROENTEROLOGY
- Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss
- (2010) Y. A. Minamishima et al. SCIENCE
- Inhibition of Prolyl Hydroxylase Domain-Containing Protein Suppressed Lipopolysaccharide-Induced TNF-α Expression
- (2009) Kotaro Takeda et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH)
- (2009) James D. Webb et al. BIOCHEMICAL JOURNAL
- Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury
- (2009) Martin Schneider et al. GASTROENTEROLOGY
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Proteomics-based Identification of Novel Factor Inhibiting Hypoxia-inducible Factor (FIH) Substrates Indicates Widespread Asparaginyl Hydroxylation of Ankyrin Repeat Domain-containing Proteins
- (2008) Matthew E. Cockman et al. MOLECULAR & CELLULAR PROTEOMICS
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
- Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism
- (2008) Julián Aragonés et al. NATURE GENETICS
- Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins
- (2007) K. Takeda et al. BLOOD
- Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
- (2007) Y. A. Minamishima et al. BLOOD
- The Hydroxylase Inhibitor Dimethyloxalylglycine Is Protective in a Murine Model of Colitis
- (2007) Eoin P. Cummins et al. GASTROENTEROLOGY
- Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition
- (2007) Andreas Robinson et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started